Clinical trial
Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical…
NCT00481728 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00481728 |
|---|---|
| Title | Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate. |
| Official title | Evaluation of Sympathetic Skin Responses and Heart Rate Variability as Objective Measures of Bladder Sensation - a Double Blind Third Party Open Placebo Controlled Randomised Study Using a Single Dose of Tolterodine in Patients With Idiopathic Overactive Bladder and Healthy Volunteers |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug, Procedure |
| Interventions | Tolterodine, Filling cystometry, Intravesical neurostimulation |
| Enrollment | 28 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 4, 2007 |
| Last update posted | Jan 27, 2021 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: